EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research

Seppala, L. J.; Guðmundsson, Aðalsteinn

Opin vísindi
→
Háskóli Íslands
→
Greinar- HÍ
→
Skoða verk

dc.contributor	Háskóli Íslands
dc.contributor	University of Iceland
dc.contributor.author	Seppala, L. J.
dc.contributor.author	Guðmundsson, Aðalsteinn
dc.date.accessioned	2020-05-04T16:52:35Z
dc.date.available	2020-05-04T16:52:35Z
dc.date.issued	2019-02-11
dc.identifier.citation	Seppala, L.J., van der Velde, N., Masud, T. et al. EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research. Drugs & Aging 36, 299–307 (2019). https://doi.org/10.1007/s40266-018-0622-7
dc.identifier.issn	1170-229X
dc.identifier.issn	1179-1969 (eISSN)
dc.identifier.uri	https://hdl.handle.net/20.500.11815/1775
dc.description	Publisher's version (útgefin grein)
dc.description.abstract	Falls are a major public health concern in the older population, and certain medication classes are a signifcant risk factor for falls. However, knowledge is lacking among both physicians and older people, including caregivers, concerning the role of medication as a risk factor. In the present statement, the European Geriatric Medicine Society (EuGMS) Task and Finish group on fall-risk-increasing drugs (FRIDs), in collaboration with the EuGMS Special Interest group on Pharmacology and the European Union of Medical Specialists (UEMS) Geriatric Medicine Section, outlines its position regarding knowledge dissemination on medication-related falls in older people across Europe. The EuGMS Task and Finish group is developing educational materials to facilitate knowledge dissemination for healthcare professionals and older people. In addition, steps in primary prevention through judicious prescribing, deprescribing of FRIDs (withdrawal and dose reduction), and gaps in current research are outlined in this position paper.
dc.description.sponsorship	This study was supported by the Clementine Brigitta Maria Dalderup fund, which is an Amsterdam University fund. The sponsor played no part in the design or preparation of this paper.
dc.format.extent	299-307
dc.language.iso	en
dc.publisher	Springer Science and Business Media LLC
dc.relation.ispartofseries	Drugs & Aging;36(4)
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	Public health
dc.subject	Fall-risk-increasing drugs
dc.subject	FRIDs
dc.subject	Lýðheilsa
dc.subject	Dettni
dc.subject	Aldraðir
dc.title	EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research
dc.type	info:eu-repo/semantics/article
dcterms.license	Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
dc.description.version	Peer Reviewed
dc.identifier.journal	Drugs & Aging
dc.identifier.doi	10.1007/s40266-018-0622-7
dc.relation.url	https://link.springer.com/article/10.1007%2Fs40266-018-0622-7
dc.contributor.department	Læknadeild (HÍ)
dc.contributor.department	Faculty of Medicine (UI)
dc.contributor.school	Heilbrigðisvísindasvið (HÍ)
dc.contributor.school	School of Health Sciences (UI)